首页|State Key Laboratory of Oncology in South China Reports Findings in Artificial I ntelligence (Association of artificial intelligence-based immunoscore with the e fficacy of chemoimmunotherapy in patients with advanced non-squamous non-small c ell ...)

State Key Laboratory of Oncology in South China Reports Findings in Artificial I ntelligence (Association of artificial intelligence-based immunoscore with the e fficacy of chemoimmunotherapy in patients with advanced non-squamous non-small c ell ...)

扫码查看
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligenc e is the subject of a report. According to newsreporting originating in Guangzh ou, People’s Republic of China, by NewsRx journalists, research stated,“Current ly, chemoimmunotherapy is effective only in a subset of patients with advanced n on-squamousnon-small cell lung cancer. Robust biomarkers for predicting the eff icacy of chemoimmunotherapy wouldbe useful to identify patients who would benef it from chemoimmunotherapy.”

GuangzhouPeople’s Republic of ChinaA siaArtificial IntelligenceBiomarkersCancerDiagnostics and ScreeningDru gs and TherapiesEmerging TechnologiesHealth and MedicineImmunologyLung C ancerLung Diseases and ConditionsLung NeoplasmsMachine LearningNon-Small Cell Lung CancerOncologyTherapy

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
年,卷(期):2024.(Dec.3)